Gambia Vaccine Industry Outlook 2024 - 2028

See how Gambia Vaccine performed compared to key markets.

Key Market Indicators

**Gambian Vaccination Coverage Projected to Decline to 86% by 2028** BANJUL, The Gambia - The vaccination coverage for one-year-old children in The Gambia is projected to decline to 86% by 2028, down from the current 88% in 2023. This represents an average annual decrease of 0.5 percentage points. The trend points to a broader decline observed since 2005, where the vaccination coverage has been decreasing at an average rate of 1.1 percentage points per year. In a related development, The Gambia's vaccine imports saw a significant increase in 2018. The value of vaccine imports surged to approximately $313,000, up from around $56,000 in 2017, marking a staggering 457% rise year over year. Despite this increase, the overall demand for vaccines in The Gambia has been declining since 2000, with an average annual decrease of 26.4%.

Gambia Vaccine Market Data and Forecasts

How much will Gambia Vaccine Market grow to 2028?

Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Gambia
Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Gambia
Forecast: Diphtheria Tetanus Toxoid and Pertussis Third Dose (DTP3) Immunization Coverage in Gambia

Other Top Countries about Vaccine